Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL

Clinical trial NCT04582487 · UNKNOWN

Trial details

NCT number: NCT04582487
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

T Acute Lymphoblastic Leukemia Early T Acute Lymphoblastic Leukemia T-lymphoblastic Lymphoma Etp All

Start date: 2021-05-19
Primary completion: 2024-05-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.